Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 14 records, 2 pages
Search For: Insulin Glargine
Global Insulin Glargine Supply, Demand and Key Producers, 2024-2030
19 Feb 2024
Pharma & Healthcare
The global Insulin Glargine market size is expected to reach $ 8978.2 million by 2030, rising at a market growth of 3.8% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Insulin Glargine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Insulin Glargine market size was valued at USD 6902.2 million in 2023 and is forecast to a readjusted size of USD 8978.2 million by 2030 with a CAGR of 3.8% during review period.
USD3480.00
Add To Cart
Global Insulin Glargine Injection Supply, Demand and Key Producers, 2024-2030
11 Feb 2024
Pharma & Healthcare
The global Insulin Glargine Injection market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Insulin Glargine Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
08 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Insulin Glargine Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Biosimilar Insulin Glargine Supply, Demand and Key Producers, 2024-2030
18 Feb 2024
Pharma & Healthcare
The global Biosimilar Insulin Glargine market size is expected to reach $ 2533.8 million by 2030, rising at a market growth of 2.7% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Biosimilar Insulin Glargine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
09 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Biosimilar Insulin Glargine market size was valued at USD 2105.6 million in 2023 and is forecast to a readjusted size of USD 2533.8 million by 2030 with a CAGR of 2.7% during review period.
USD3480.00
Add To Cart
Global Insulin Glargine and Lispro Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Insulin Glargine and Lispro market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Insulin Glargine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
18 Mar 2023
Pharma & Healthcare
nsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).
USD3480.00
Add To Cart
Global Insulin Glargine Injection Supply, Demand and Key Producers, 2023-2029
16 Feb 2023
Pharma & Healthcare
The global Insulin Glargine Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Global Insulin Glargine Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
16 Feb 2023
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Insulin Glargine Injection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
USD3480.00
Add To Cart
- 1
- 2
Go To Page
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Insulin Glargine
Total: 14 records, 2 pages
The global Insulin Glargine market size is expected to reach $ 8978.2 million by 2030, rising at a market growth of 3.8% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Insulin Glargine market size was valued at USD 6902.2 million in 2023 and is forecast to a readjusted size of USD 8978.2 million by 2030 with a CAGR of 3.8% during review period.
USD3480.00
Add To Cart
The global Insulin Glargine Injection market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Insulin Glargine Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
The global Biosimilar Insulin Glargine market size is expected to reach $ 2533.8 million by 2030, rising at a market growth of 2.7% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Biosimilar Insulin Glargine market size was valued at USD 2105.6 million in 2023 and is forecast to a readjusted size of USD 2533.8 million by 2030 with a CAGR of 2.7% during review period.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Insulin Glargine and Lispro market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
nsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).
USD3480.00
Add To Cart
The global Insulin Glargine Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Insulin Glargine Injection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
USD3480.00
Add To Cart
- 1
- 2
Go To Page
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>